BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma A, Liaw K, Sharma R, Spriggs T, Appiani La Rosa S, Kannan S, Kannan RM. Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma. Biomacromolecules 2020;21:5148-61. [PMID: 33112134 DOI: 10.1021/acs.biomac.0c01270] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Porterfield JE, Sharma R, Jimenez AS, Sah N, Mccracken S, Zhang L, An H, Lee S, Kannan S, Sharma A, Kannan RM. Galactosylated hydroxyl‐ polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning‐induced liver failure. Bioengineering & Transla Med 2023. [DOI: 10.1002/btm2.10486] [Reference Citation Analysis]
2 Gaitsch H, Hersh AM, Alomari S, Tyler BM. Dendrimer Technology in Glioma: Functional Design and Potential Applications. Cancers (Basel) 2023;15. [PMID: 36831418 DOI: 10.3390/cancers15041075] [Reference Citation Analysis]
3 Sahoo RK, Kumar V, Batheja S, Gupta U. Dendrimers in the effective management of Alzheimer’s and dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 2023. [DOI: 10.1016/b978-0-12-824331-2.00003-0] [Reference Citation Analysis]
4 Wang Z, Zhong H, Liang X, Ni S. Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape. Front Immunol 2022;13:1024921. [DOI: 10.3389/fimmu.2022.1024921] [Reference Citation Analysis]
5 Nemeth CL, Gӧk Ö, Tomlinson SN, Sharma A, Moser AB, Kannan S, Kannan RM, Fatemi A. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy. Neurotherapeutics 2022;:1-12. [PMID: 36207570 DOI: 10.1007/s13311-022-01311-x] [Reference Citation Analysis]
6 Tallon C, Bell BJ, Sharma A, Pal A, Malvankar MM, Thomas AG, Yoo SW, Hollinger KR, Coleman K, Wilkinson EL, Kannan S, Haughey NJ, Kannan RM, Rais R, Slusher BS. Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice. Pharmaceutics 2022;14. [PMID: 36297501 DOI: 10.3390/pharmaceutics14102066] [Reference Citation Analysis]
7 Sahoo RK, Gupta T, Batheja S, Goyal AK, Gupta U. Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme. Curr Drug Metab 2022;23:708-22. [PMID: 35713127 DOI: 10.2174/1389200223666220616125524] [Reference Citation Analysis]
8 Fekrirad Z, Barzegar Behrooz A, Ghaemi S, Khosrojerdi A, Zarepour A, Zarrabi A, Arefian E, Ghavami S. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers 2022;14:3698. [DOI: 10.3390/cancers14153698] [Reference Citation Analysis]
9 Tang L, Zhang M, Liu C. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma. Front Immunol 2022;13:882257. [DOI: 10.3389/fimmu.2022.882257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nie X, Zhang X, Lei B, Shi Y, Yang J. Regulation of Magnesium Matrix Composites Materials on Bone Immune Microenvironment and Osteogenic Mechanism. Front Bioeng Biotechnol 2022;10:842706. [DOI: 10.3389/fbioe.2022.842706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu Z, Ji X, He D, Zhang R, Liu Q, Xin T. Nanoscale Drug Delivery Systems in Glioblastoma. Nanoscale Res Lett 2022;17:27. [PMID: 35171358 DOI: 10.1186/s11671-022-03668-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Hollinger KR, Sharma A, Tallon C, Lovell L, Thomas AG, Zhu X, Wiseman R, Wu Y, Kambhampati SP, Liaw K, Sharma R, Rojas C, Rais R, Kannan S, Kannan RM, Slusher BS. Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis. Nanotheranostics 2022;6:126-42. [PMID: 34976589 DOI: 10.7150/ntno.63158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Poudel DP, Taylor RT. Thiol-Ene Click-Inspired Late-Stage Modification of Long-Chain Polyurethane Dendrimers. Reactions 2022;3:12-29. [DOI: 10.3390/reactions3010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Tang L, Feng Y, Gao S, Mu Q, Liu C. Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment. Front Pharmacol 2021;12:786700. [PMID: 34899350 DOI: 10.3389/fphar.2021.786700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
15 Sharma A, Sah N, Kannan S, Kannan RM. Targeted drug delivery for maternal and perinatal health: Challenges and opportunities. Adv Drug Deliv Rev 2021;177:113950. [PMID: 34454979 DOI: 10.1016/j.addr.2021.113950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Huo D, Li M, Zhao Z, Wang X, Xia A, Lu P, Wan Y. Delocalized Excitation or Intramolecular Energy Transfer in Pyrene Core Dendrimers. J Phys Chem Lett 2021;12:7717-25. [PMID: 34355904 DOI: 10.1021/acs.jpclett.1c02182] [Reference Citation Analysis]
17 Sharma R, Porterfield JE, An HT, Jimenez AS, Lee S, Kannan S, Sharma A, Kannan RM. Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders. Biomacromolecules 2021;22:3574-89. [PMID: 34324818 DOI: 10.1021/acs.biomac.1c00649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sharma R, Liaw K, Sharma A, Jimenez A, Chang M, Salazar S, Amlani I, Kannan S, Kannan RM. Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma. J Control Release 2021;337:179-92. [PMID: 34274384 DOI: 10.1016/j.jconrel.2021.07.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
19 Song P, Song N, Li L, Wu M, Lu Z, Zhao X. Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma. Biomacromolecules 2021;22:2921-2934. [DOI: 10.1021/acs.biomac.1c00314] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
20 Tan G, Li J, Liu D, Pan H, Zhu R, Yang Y, Pan W. Amino acids functionalized dendrimers with nucleus accumulation for efficient gene delivery. International Journal of Pharmaceutics 2021;602:120641. [DOI: 10.1016/j.ijpharm.2021.120641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ma J, Chen CC, Li M. Macrophages/Microglia in the Glioblastoma Tumor Microenvironment. Int J Mol Sci 2021;22:5775. [PMID: 34071306 DOI: 10.3390/ijms22115775] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]